Lung cancer vaccine MAGE-A3 does not improve disease-free survival in resected lung cancer

At ESMO 2014, Prof Johan F. Vansteenkiste presents the results of a phase III trial (MAGRIT). The results show that MAGE-A3 cancer immunotherapy in patients with resected NSCLC does not increase disea... Author: EMJ Added: 10/03/2014
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts